Unveiling novel susceptibility genes for sarcoidosis by a cross-tissue transcriptome-wide association study.
Sarcoidosis vasculitis and diffuse lung diseases · 22.06.2026 · 43 (2) · 18029-18029
DOI: 10.36141/svdld.2026.18029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 22.06.2026. Verfasst von Xiqiao Sun. Beteiligte Einrichtung: Zhongshan School of Medicine, Sun Yat-sen University. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Sarcoidosis is a systemic granulomatous disease with heterogeneous clinical manifestations and unclear pathogenesis. Although genome-wide association studies (GWAS) have identified several immune-related loci, the functional interpretation of these signals remains limited. Integrative transcriptome-wide approaches may uncover novel susceptibility genes and provide mechanistic insights. OBJECTIVES: The primary objective of this study was to identify novel susceptibility genes for sarcoidosis and provide mechanistic insights into its pathogenesis through a comprehensive, cross-tissue transcriptome-wide approach. METHODS: We conducted a cross-tissue transcriptome-wide association study (TWAS) using the UTMOST framework, followed by single-tissue TWAS via FUSION. Candidate genes identified in both analyses were further evaluated using Multi-marker Analysis of Genomic Annotation (MAGMA), Mendelian randomization (MR), and Bayesian colocalization. Functional characterization was explored through gene-chemical-disease associations from the Comparative Toxicogenomics Database (CTD) and phenome-wide association studies (PheWAS) in the UK Biobank. RESULTS: Cross-tissue TWAS identified 48 genes. Integrative analyses prioritized four novel susceptibility genes: RNF215, PLCL1, FAM117B, and RFTN2. MR and colocalization supported causal effects of RNF215 (risk-increasing), FAM117B and RFTN2 (protective), and tissue-dependent effects for PLCL1. CTD analyses revealed interactions of these genes with environmental chemicals including bisphenol A and tetrachlorodibenzodioxin, while PheWAS demonstrated pleiotropic associations with immune, respiratory, hematological, and cardiovascular traits. CONCLUSIONS: This comprehensive integrative study identifies four biologically plausible susceptibility genes for sarcoidosis, expanding the genetic architecture of sarcoidosis and suggest potential targets for mechanistic and therapeutic investigation.
Schlagwörter
Autor:innen und Institutionen
- Zhongshan School of Medicine, Sun Yat-sen University.
ORCID-Profile: Xiqiao Sun
Zitieren
APA
Sun, X. (2026). Unveiling novel susceptibility genes for sarcoidosis by a cross-tissue transcriptome-wide association study. Sarcoidosis vasculitis and diffuse lung diseases, 43(2), 18029-18029. https://doi.org/10.36141/svdld.2026.18029
Vancouver
Sun X. Unveiling novel susceptibility genes for sarcoidosis by a cross-tissue transcriptome-wide association study. Sarcoidosis vasculitis and diffuse lung diseases. 2026;43(2):18029-18029. doi:10.36141/svdld.2026.18029
BibTeX
@article{Sun2026,
author = {Sun, Xiqiao},
title = {Unveiling novel susceptibility genes for sarcoidosis by a cross-tissue transcriptome-wide association study},
journal = {Sarcoidosis vasculitis and diffuse lung diseases},
year = {2026},
volume = {43},
number = {2},
pages = {18029--18029},
doi = {10.36141/svdld.2026.18029}
}
EUVIMED